Vanguard Asset Management »

Royalty Pharma shares owned by Vanguard Asset Management

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Vanguard Asset Management from 13F filings

Historical chart of Vanguard Asset Management investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Vanguard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Vanguard Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $39M 806k 47.97

More positions owned by Vanguard Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Astrazeneca Ord (AZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Johnson & Johnson (JNJ)

View all positions for Vanguard Asset Management

Top funds holding Royalty Pharma

Morgan Stanley
Capital Research and Management Company - Division 3
FMR
BlackRock
Baillie Gifford & Co
Adage Capital Partners GP
Swedbank AB
State Street Corporation
Vanguard Group
Capital World Investors
Geode Capital Management
Caledonia
Victory Capital Management
Vanguard Capital Management
Northern Trust

View all funds holding Royalty Pharma